Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Whalen

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Current Pain and Headache Reports|October 7, 2018
A Short Review of the Treatment of Headaches Using Osteopathic Manipulative TreatmentJohn Whalen, Sheldon Yao, Adena Leder
World Neurosurgery|March 31, 2025
Nontumoral Amygdalar Enlargement in Tumoral EpilepsySubeikshanan Venkatesan, John Whalen, Giridhar Kalamangalam
Journal of Medical Economics|June 22, 2022
The cost-effectiveness of abobotulinumtoxinA (Dysport) and onabotulinumtoxinA (Botox) for managing spasticity of the upper and lower limbs, and cervical dystoniaNatalya Danchenko, Karissa M Johnston, John Whalen
ACS Applied Materials & Interfaces|April 2, 2010
Stimuli-responsive epoxy coatingsLiming Tang, John Whalen, Grant Schutte, et al.
Cognitive Neuropsychology|October 20, 2010
Representing arithmetic table facts in memory: Evidence from acquired impairmentsJohn Whalen, Michael McCloskey, Margarethe Lindemann, et al.
Harvard Business Review|May 17, 2014
The collaboration imperativeRam Nidumolu, Jib Ellison, John Whalen, et al.
Journal of Medical Economics|November 28, 2015
Cost-effectiveness analysis of second-line tyrosine kinase inhibitor treatment for chronic myelogenous leukemiaJohn Whalen, Ipek Stillman, Apoorva Ambavane, et al.
Journal of Medical Economics|January 17, 2023
Efficacy of abobotulinumtoxinA versus onabotulinumtoxinA for the treatment of refractory neurogenic detrusor overactivity: a systematic review and indirect treatment comparisonFrancisco Cruz, Natalya Danchenko, Kyle Fahrbach, et al.
International Journal of Environmental Research and Public Health|December 14, 2011
Validation of walk score for estimating neighborhood walkability: an analysis of four US metropolitan areasDustin T Duncan, Jared Aldstadt, John Whalen, et al.
Advances in Therapy|June 21, 2025
The Impact of Activated Phosphoinositide 3-Kinase δ Syndrome (APDS) on Health-Related Quality of Life (HRQoL): Elicitation of Health State Utility Values Through Time Trade-Off (TTO) and EQ-5DJoanne B Tutein Nolthenius, Annabel Griffiths, Olivia Dodd, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Current Pain and Headache Reports|October 7, 2018
A Short Review of the Treatment of Headaches Using Osteopathic Manipulative TreatmentJohn Whalen, Sheldon Yao, Adena Leder
World Neurosurgery|March 31, 2025
Nontumoral Amygdalar Enlargement in Tumoral EpilepsySubeikshanan Venkatesan, John Whalen, Giridhar Kalamangalam
Journal of Medical Economics|June 22, 2022
The cost-effectiveness of abobotulinumtoxinA (Dysport) and onabotulinumtoxinA (Botox) for managing spasticity of the upper and lower limbs, and cervical dystoniaNatalya Danchenko, Karissa M Johnston, John Whalen
ACS Applied Materials & Interfaces|April 2, 2010
Stimuli-responsive epoxy coatingsLiming Tang, John Whalen, Grant Schutte, et al.
Cognitive Neuropsychology|October 20, 2010
Representing arithmetic table facts in memory: Evidence from acquired impairmentsJohn Whalen, Michael McCloskey, Margarethe Lindemann, et al.
Harvard Business Review|May 17, 2014
The collaboration imperativeRam Nidumolu, Jib Ellison, John Whalen, et al.
Journal of Medical Economics|November 28, 2015
Cost-effectiveness analysis of second-line tyrosine kinase inhibitor treatment for chronic myelogenous leukemiaJohn Whalen, Ipek Stillman, Apoorva Ambavane, et al.
Journal of Medical Economics|January 17, 2023
Efficacy of abobotulinumtoxinA versus onabotulinumtoxinA for the treatment of refractory neurogenic detrusor overactivity: a systematic review and indirect treatment comparisonFrancisco Cruz, Natalya Danchenko, Kyle Fahrbach, et al.
International Journal of Environmental Research and Public Health|December 14, 2011
Validation of walk score for estimating neighborhood walkability: an analysis of four US metropolitan areasDustin T Duncan, Jared Aldstadt, John Whalen, et al.
Advances in Therapy|June 21, 2025
The Impact of Activated Phosphoinositide 3-Kinase δ Syndrome (APDS) on Health-Related Quality of Life (HRQoL): Elicitation of Health State Utility Values Through Time Trade-Off (TTO) and EQ-5DJoanne B Tutein Nolthenius, Annabel Griffiths, Olivia Dodd, et al.
Pageof 3